Total pelvic exenteration for primary local advanced colorectal cancer

Han Shiang Chen, Shyr Ming Sheen-Chen

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

Total pelvic exenteration (TPE) is an ultraradical operative procedure for locally advanced pelvic tumors with high morbidity and mortality rates. We retrospectively reviewed the results of TPE for primary locally advanced colorectal cancer in terms of mortality, morbidity, and long-term survival. Of 2952 patients with colorectal cancer, 50 underwent TPE for primary locally advanced colorectal cancer between 1986 and 1995. There was one operative death (2%). The other 49 cases were entered into a retrospective study. Thirty-two cases (65%) showed involvement of one or more adjacent organs. Thirty-one patients (97%) had urologic organs invaded by tumor. The overall 5-year survival rate was 49% and the overall morbidity was 37%. The survival rate for stage II was 62%, and that for stage III was 35%; there was no survival in stage IV. Early morbidity was noted in 24% of patients; late morbidity, in 15%. TNM stage appeared to be the only independent factor for survival (p = 0.022). Our study showed that TPE can be performed with relatively low operative mortality and acceptable morbidity. With thorough preoperative evaluation and adequate surgical dissection, satisfactory outcomes for a primary locally advanced colorectal cancer can be achieved, especially at the earlier stages.

Original languageEnglish
Pages (from-to)1546-1549
Number of pages4
JournalWorld Journal of Surgery
Volume25
Issue number12
DOIs
Publication statusPublished - Dec 1 2001
Externally publishedYes

Fingerprint

Pelvic Exenteration
Colorectal Neoplasms
Morbidity
Survival
Mortality
Survival Rate
Operative Surgical Procedures
Dissection
Neoplasms
Retrospective Studies

ASJC Scopus subject areas

  • Surgery

Cite this

Total pelvic exenteration for primary local advanced colorectal cancer. / Chen, Han Shiang; Sheen-Chen, Shyr Ming.

In: World Journal of Surgery, Vol. 25, No. 12, 01.12.2001, p. 1546-1549.

Research output: Contribution to journalArticle

@article{a90a4b8a887d4cb6aca8402649281b62,
title = "Total pelvic exenteration for primary local advanced colorectal cancer",
abstract = "Total pelvic exenteration (TPE) is an ultraradical operative procedure for locally advanced pelvic tumors with high morbidity and mortality rates. We retrospectively reviewed the results of TPE for primary locally advanced colorectal cancer in terms of mortality, morbidity, and long-term survival. Of 2952 patients with colorectal cancer, 50 underwent TPE for primary locally advanced colorectal cancer between 1986 and 1995. There was one operative death (2{\%}). The other 49 cases were entered into a retrospective study. Thirty-two cases (65{\%}) showed involvement of one or more adjacent organs. Thirty-one patients (97{\%}) had urologic organs invaded by tumor. The overall 5-year survival rate was 49{\%} and the overall morbidity was 37{\%}. The survival rate for stage II was 62{\%}, and that for stage III was 35{\%}; there was no survival in stage IV. Early morbidity was noted in 24{\%} of patients; late morbidity, in 15{\%}. TNM stage appeared to be the only independent factor for survival (p = 0.022). Our study showed that TPE can be performed with relatively low operative mortality and acceptable morbidity. With thorough preoperative evaluation and adequate surgical dissection, satisfactory outcomes for a primary locally advanced colorectal cancer can be achieved, especially at the earlier stages.",
author = "Chen, {Han Shiang} and Sheen-Chen, {Shyr Ming}",
year = "2001",
month = "12",
day = "1",
doi = "10.1007/s00268-001-0167-4",
language = "English",
volume = "25",
pages = "1546--1549",
journal = "World Journal of Surgery",
issn = "0364-2313",
publisher = "Springer New York LLC",
number = "12",

}

TY - JOUR

T1 - Total pelvic exenteration for primary local advanced colorectal cancer

AU - Chen, Han Shiang

AU - Sheen-Chen, Shyr Ming

PY - 2001/12/1

Y1 - 2001/12/1

N2 - Total pelvic exenteration (TPE) is an ultraradical operative procedure for locally advanced pelvic tumors with high morbidity and mortality rates. We retrospectively reviewed the results of TPE for primary locally advanced colorectal cancer in terms of mortality, morbidity, and long-term survival. Of 2952 patients with colorectal cancer, 50 underwent TPE for primary locally advanced colorectal cancer between 1986 and 1995. There was one operative death (2%). The other 49 cases were entered into a retrospective study. Thirty-two cases (65%) showed involvement of one or more adjacent organs. Thirty-one patients (97%) had urologic organs invaded by tumor. The overall 5-year survival rate was 49% and the overall morbidity was 37%. The survival rate for stage II was 62%, and that for stage III was 35%; there was no survival in stage IV. Early morbidity was noted in 24% of patients; late morbidity, in 15%. TNM stage appeared to be the only independent factor for survival (p = 0.022). Our study showed that TPE can be performed with relatively low operative mortality and acceptable morbidity. With thorough preoperative evaluation and adequate surgical dissection, satisfactory outcomes for a primary locally advanced colorectal cancer can be achieved, especially at the earlier stages.

AB - Total pelvic exenteration (TPE) is an ultraradical operative procedure for locally advanced pelvic tumors with high morbidity and mortality rates. We retrospectively reviewed the results of TPE for primary locally advanced colorectal cancer in terms of mortality, morbidity, and long-term survival. Of 2952 patients with colorectal cancer, 50 underwent TPE for primary locally advanced colorectal cancer between 1986 and 1995. There was one operative death (2%). The other 49 cases were entered into a retrospective study. Thirty-two cases (65%) showed involvement of one or more adjacent organs. Thirty-one patients (97%) had urologic organs invaded by tumor. The overall 5-year survival rate was 49% and the overall morbidity was 37%. The survival rate for stage II was 62%, and that for stage III was 35%; there was no survival in stage IV. Early morbidity was noted in 24% of patients; late morbidity, in 15%. TNM stage appeared to be the only independent factor for survival (p = 0.022). Our study showed that TPE can be performed with relatively low operative mortality and acceptable morbidity. With thorough preoperative evaluation and adequate surgical dissection, satisfactory outcomes for a primary locally advanced colorectal cancer can be achieved, especially at the earlier stages.

UR - http://www.scopus.com/inward/record.url?scp=0035675568&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035675568&partnerID=8YFLogxK

U2 - 10.1007/s00268-001-0167-4

DO - 10.1007/s00268-001-0167-4

M3 - Article

C2 - 11775189

AN - SCOPUS:0035675568

VL - 25

SP - 1546

EP - 1549

JO - World Journal of Surgery

JF - World Journal of Surgery

SN - 0364-2313

IS - 12

ER -